Академический Документы
Профессиональный Документы
Культура Документы
Lecturer of psychiatry
Prenatal Classes
Newspaper articles
Community lectures
◦ Proper nutrition
◦ Avoidance of isolation
Type of illness (bipolar)
Severity
Medications needed
Infant issues
Individual patient approach is needed
Precious baby
Psychotropics
Social Support
Psychotherapy
ECT
Psychosocial therapies
◦ Cognitive-behavioral therapy
Peer-support groups
Four factors are needed in order to understand
problems related to breast-feeding by mothers taking
psychotropic medication:
• Metabolism
• Renal clearance
During the first few days of life there are large gaps
between these alveolar cells, which allow most
molecules to cross through easily.
For psychotropics the arbitrary concentration in the
infant’s plasma of 10% of the established therapeutic
maternal dose is used as the upper threshold where the
risks of a particular drug’s side-effects are low and
treatment is accepted as safe
The newborn’s health should be taken into
consideration when planning breast-feeding
Close follow-up
SSRI
SSRI preferred initially.
Drug levels are low to undetectable.
All effective in open trials (Moretti, 2009).
SSRIs such as fluoxetine, sertraline, paroxetine and
citalopram are safe during breast-feeding (Berle, 2004).
Sertraline is considered as first line in USA (Altshuler
et al. (2001).
Tricyclics have a less favorable side effect profile and a
much higher risk of morbidity and mortality from
overdose.
However, it is relatively safer and low levels of drugs
are secreted for most tricyclics.
Tricyclics such as amitryptyline, imipramine,
nortriptyline and clomipramine are safe during breast-
feeding (Becker, 2009).
Doxepin is contraindicated (respiratory depression).
Trazodone appears to be of lower risk because only 1%
passes into the milk, although drowsiness and poor
feeding have been reported. Data are limited to a few
cases and caution is advised in use of the drug.
- It has been mentioned in certain studies that
Mirtazapine can be used as first-line treatment and,
because of its action on histamine H1 receptors, may be
preferred in some patients with postnatal depression,
when night-time sedation is required (Snellen, 2007)
Venlafaxine is considered safe (Snellen, 2007).